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We present a case of renal cell carcinoma with prominent inflammatory and paraneoplastic manifesta-
tions. The initial CT detection of renal malignancy and subsequent post-therapeutic F-18 FDG PET/
CT diagnosis of occult osseous metastasis were based on the patient’s anemia, thrombocytosis and 
abnormally increased levels of serum C-reactive protein.
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 Renal cell carcinoma is one of the most common 
malignant neoplasms of the genitourinary system. It is 
more frequently detected as an incidental finding during 
cross-sectional imaging evaluation of unrelated pathology 
than diagnosed at advanced and disseminated stages of the 
disease. Awareness of paraneoplastic manifestations such 
as anemia, thrombocytosis and elevated serum C-reactive 
protein may prompt clinicians to use various anatomic and 
functional imaging modalities for diagnosis and post-oper-
ative monitoring of renal cell carcinoma.
Introduction
Figure 1. 67-year-old man with renal cell carcinoma 
with paraneoplastic manifestations. Axial CT image of 
the abdomen shows a lobulated and heterogeneously 
enhancing mass arising from the lower aspect of the left 
kidney (arrows).
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Case Report
anemia (hemoglobin level: 9.9 g/dl), elevated serum C-
reactive protein (57 mg/l), thrombocytosis (platelet count: 
533,000/mm3), elevated sedimentation rate (77 mm/h) 
and low grade fever ranging from 99 to 100 degrees Fahr-
enheit. Clinical and laboratory evaluation detected no in-
A 67-year-old man presented with unexplained mild 
Discussion
 Renal cell carcinoma (RCC) is the third most com-
mon genitourinary malignant tumor and the sixth leading 
cause of cancer death in the United States [1, 2]. With 
the advent of rapid and efficient cross-sectional imaging, 
RCC is frequently diagnosed as a fortuitous finding during 
assessment of unrelated diseases. Nowadays, the classic 
triad of gross hematuria, flank pain and flank mass is rarely 
the initial clinical presentation leading to the detection 
of this malignancy [1, 2]. During the pre-diagnosis phase 
of RCC, patients may present with non-specific paraneo-
plastic manifestations, which represent valuable diagnostic 
clues for renal malignancy. These paraneoplastic syndromes 
are probably induced by substances released from the neo-
plasm itself or the patient’s immune system in reaction to 
the malignancy. Anemia, weight loss and fever are the most 
commonly encountered paraneoplastic syndromes of RCC 
in 30-50%, 20-33% and 7-25% of all cases respectively 
[1, 2]. In addition, thrombocytosis and elevated serum C-
Renal Cell Carcinoma with Paraneoplastic Manifestations:  
Imaging with CT and F-18 FDG PET/CT
Figure 3. Composite F-18 FDG PET/CT image of the left 
pelvis (image sequence: CT, PET, and fused PET/CT in 
coronal, sagittal and axial projections) shows abnormal 
radiotracer accumulation in the left iliac bone and left 
acetabulum suggestive of hypermetabolic bone lesions 
(arrows). The transmission CT of this composite image 
shows no obvious lesion to match the PET findings.
Figure 2. Composite PET image (sequence: coronal, 
sagittal, axial and volumetric images) shows increased F-
18 FDG uptake at the left iliac bone, left acetabulum and 
left ischium compatible with hypermetabolic osseous le-
sions (small arrows). The patient is status left nephrecto-
my with absent activity in the left renal fossa (arrowhead).
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fectious etiology. Bone marrow biopsy was unremarkable. 
A CT scan performed to search for malignancy showed a 5 
cm heterogeneously enhancing solid mass in the lower pole 
of the left kidney compatible with a renal neoplasm (Fig. 
1). The patient underwent left laparoscopic radical neph-
rectomy, which confirmed a renal cell carcinoma (RCC), 
predominantly of clear cell type, Fuhrman grade 3. The 
tumor involved the renal capsule but did not extend to the 
perinephric adipose tissue. There was no tumor invasion of 
the left renal pelvis or left renal vein. Post-operatively, there 
was resolution of the anemia and the serum C-reactive 
protein returned to the normal range (2.99 mg/l). Eight 
months after the initial surgery, the patient had recurrence 
of mild anemia (hemoglobin level: 10.5 g/dl) and throm-
bocytosis (platelet count: 523,000/mm3), re-elevation of 
serum C-reactive protein (30 mg/l) and new onset of low 
grade fever up to 100.5 degrees. Serial CT examinations of 
the chest, abdomen and pelvis were negative for recur-
rent or metastatic RCC. A month later, there was further 
increase in the serum C-reactive protein level (94 mg/l). 
As seen initially, all cultures and serologies were negative 
for infectious causes. Positron emission tomography (PET) 
with 2-Deoxy-2-(F-18) fluoro-D-glucose (FDG) was ob-
tained to search for potential CT-occult secondary malig-
nancy. PET showed abnormal radiotracer uptake at the left 
iliac crest, acetabulum and ischium without corresponding 
bone lesions on concomitant transmission CT (Fig. 2 & 
3). Due to the lack of CT information, PET/CT fusion 
images were used to guide osseous tissue sampling. The 
bone biopsy yielded metastasis from renal cell carcinoma.
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